Tannic acid inhibits hepatitis C virus entry into Huh7.5 cells

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Liu, Shuanghu ^a,b   Chen, Ren ^b   Hagedorn, Curt H ^b,c,d,e  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TANNIN; ANTIVIRUS AGENT; LUCIFERASE; TANNIN DERIVATIVE;

ARTICLE; CELL PROLIFERATION; CELL SPREADING; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUH7.5 CELL; HUMAN; HUMAN CELL; IC50; MOLECULAR DOCKING; NONHUMAN; PHARMACOLOGICAL BLOCKING; STRUCTURE ANALYSIS; TOXICITY ASSAY; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEPACIVIRUS; LIVER CELL; METABOLISM; PATHOLOGY; REPLICON; REPORTER GENE; TUMOR CELL LINE; VIROLOGY;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION; GENES, REPORTER; HEPACIVIRUS; HEPATOCYTES; HUMANS; LUCIFERASES; REPLICON; TANNINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84941352733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131358     Document Type: Article

References (67)

1. Bialek SR, Terrault NA (2006) The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 10:697-715. PMID: 17164113
2. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567. PMID: 16122679
3. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547-6549. PMID: 2168552
4. Shiina M, Rehermann B (2006) Hepatitis C vaccines: Inducing and challenging memory T cells. Hepatology 43:1395-1398. PMID: 16729320
5. Manns MP, Wedemeyer H, Cornberg M (2006) Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55:1350-1359. PMID: 16905701
6. Asselah T, Marcellin P (2011) New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int 31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x PMID: 21205141
7. Poordad F, McCone J Jr., Bacon BR, Bruno S, Manns MP, Sulkowski MS, et al. (2011) Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 364:1195-1206. doi: 10.1056/NEJMoa1010494 PMID: 21449783
8. Sarrazin C, Zeuzem S (2010) Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138:447-462. doi: 10.1053/j.gastro.2009.11.055 PMID: 20006612
9. Reed KE, Rice CM (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55-84. PMID: 10592656
10. Yi M, Ma Y, Yates J, Lemon SM (2007) Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81:629638.
11. Farquhar MJ, Harris HJ, McKeating JA (2011) Hepatitis C virus entry and the tetraspanin CD81. Biochem Soc Trans 39:532-536. doi: 10.1042/BST0390532 PMID: 21428934
12. Bartosch B, Dubuisson J (2010) Recent advances in hepatitis C virus cell entry. Viruses 2:692709.
13. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, et al. 2006. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80:6964-6972. PMID: 16809302
14. Zeisel MB, Felmlee DJ, Baumert TF (2013) Hepatitis C virus entry. Curr Top Microbiol Immunol 369:87-112. doi: 10.1007/978-3-642-27340-7-4 PMID: 23463198
15. Zeisel MB, Lupberger J, Fofana I, Baumert TF (2013) Host-targeting agents for prevention and treatment of chronic hepatitis C-perspectives and challenges. J Hepatol 58:375-384. doi: 10.1016/j.jhep. 2012.09.022 PMID: 23041307
16. Zeisel MB, Fofana I, Fafi-Kremer S, Baumert TF (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 54:566-576. doi: 10.1016/j.jhep. 2010. 10.014 PMID: 21146244
17. Bartosch B, Dubuisson J, Cosset FL (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633-642. PMID: 12615904
18. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, et al. (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 100:7271-7276. PMID: 12761383
19. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791-796. PMID: 15951748
20. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102:9294-9299. PMID: 15939869
21. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, et al. (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80:5308-5320. PMID: 16699011
22. Meuleman P, Hesselgesser J, Paulson M, Vanwolleghem T, Desombere I, Reiser H, et al. (2008) Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48:1761-1768. doi: 10. 1002/hep. 22547 PMID: 19030166
23. Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, et al. (2010) Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 51:1144-1157. doi: 10.1002/hep. 23445 PMID: 20069648
24. Baldick CJ, Wichroski MJ, Pendri A, Walsh AW, Fang J, Mazzucco CE, et al. (2010) A novel small molecule inhibitor of hepatitis C virus entry. PLoS Pathog 6:e1001086. doi: 10.1371/journal.ppat.1001086 PMID: 20838466
25. Serrano J, Puupponen-Pimia R, Dauer A, Aura AM, Saura-Calixto F (2009) Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 53 Suppl 2:S310-329. doi: 10.1002/mnfr.200900039 PMID: 19437486
26. Okuda T, Yoshida T, Hatano T (1995) Hydrolyzable tannins and related polyphenols. Fortschr Chem Org Naturst 66:1-117. PMID: 8847006
27. Glick Z, Joslyn MA (1970) Food intake depression and other metabolic effects of tannic acid in the rat. J Nutr 100:509-515. PMID: 5443822
28. Liu X, Kim JK, Li Y, Li J, Liu F, Chen X (2005) Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 135:165-171. PMID: 15671208
29. Chung KT, Wong TY, Wei CI, Huang YW, Lin Y (1998) Tannins and human health: a review. Critical reviews in food science and nutrition 38:421-464. PMID: 9759559
30. Savolainen H (1992) Tannin content of tea and coffee. J Appl Toxicol 12:191-192. PMID: 1629514
31. Uchiumi F, Sato T, Tanuma S (1998) Identification and characterization of a tannic acidresponsive negative regulatory element in the mouse mammary tumor virus promoter. J Biol Chem 273:12499-12508. PMID: 9575208
32. Devi MA, Das NP (1993) In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2. Cancer Lett 69:191-196. PMID: 8513446
33. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M, et al. (2000) Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines-a possible mechanism. Phytomedicine 7:39-47. PMID: 10782489
34. Pan MH, Lin JH, Lin-Shiau SY, Lin JK (1999) Induction of apoptosis by penta-O-galloyl-beta-Dglucose through activation of caspase-3 in human leukemia HL-60 cells. Eur J Pharmacol 381:171-183. PMID: 10554885
35. Wang CC, Chen LG, Yang L (2000) Cuphiin D1, the macrocyclic hydrolyzable tannin induced apoptosis in HL-60 cell line. Cancer Lett 149:77-83. PMID: 10737711
36. Koide T, Kamei H, Hashimoto Y, Kojima T, Hasegawa M (1999) Tannic acid raises survival rate of mice bearing syngeneic tumors. Cancer Biother Radiopharm 14:231-234. PMID: 10850307
37. Tikoo K, Tamta A, Ali IY, Gupta J, Gaikwad AB (2008) Tannic acid prevents azidothymidine (AZT) induced hepatotoxicity and genotoxicity along with change in expression of PARG and histone H3 acetylation. Toxicol Lett 177:90-96. doi: 10.1016/j.toxlet.2007.12.012 PMID: 18291603
38. Di Pasquale G, Ostedgaard L, Vermeer D, Swaim WD, Karp P, Chiorini JA (2012) Bovine AAV transcytosis inhibition by tannic acid results in functional expression of CFTR in vitro and altered biodistribution in vivo. Gene Ther 19:576-581. doi: 10.1038/gt.2011.138 PMID: 22011646
39. Zhang XF, Dai YC, Zhong W, Tan M, Lv ZP, Zhou YC, et al. (2012) Tannic acid inhibited norovirus binding to HBGA receptors, a study of 50 Chinese medicinal herbs. Bioorg Med Chem 20:1616-1623. doi: 10.1016/j.bmc.2011.11.040 PMID: 22285570
40. Uchiumi F, Maruta H, Inoue J, Yamamoto T, Tanuma S (1996) Inhibitory effect of tannic acid on human immunodeficiency virus promoter activity induced by 12-O-tetra decanoylphorbol-13acetate in Jurkat T-cells. Biochem Biophys Res Commun 220:411-417. PMID: 8645319
41. Theisen LL, Erdelmeier CA, Spoden GA, Boukhallouk F, Sausy A, Florin L, et al. (2014) Tannins from Hamamelis virginiana Bark Extract: Characterization and Improvement of the Antiviral Efficacy against Influenza A Virus and Human Papillomavirus. PLoS One 9:e88062. doi: 10.1371/journal.pone. 0088062 PMID: 24498245
42. Ciesek S, Von Hahn T, Colpitts CC, Schang LM, Friesland M, Steinmann J, et al. (2011) The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 54:1947-1955. doi: 10.1002/hep. 24610 PMID: 21837753
43. Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, et al. (2012). (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55:720-729. doi: 10.1002/hep. 24803 PMID: 22105803
44. Ono K, Hasegawa K, Naiki H, Yamada M (2004) Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochim Biophys Acta 1690:193202.
45. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, et al. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15:558-566. doi: 10.1038/nsmb.1437 PMID: 18511942
46. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76:13001-13014. PMID: 12438626
47. Liu S, Xiao L, Nelson C, Hagedorn CH (2012) A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses. PLoS One 7:e44965. doi: 10.1371/journal.pone.0044965 PMID: 23028707
48. Krieger N, Lohmann V, Bartenschlager R (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75:4614-4624. PMID: 11312331
49. Liu S, Chen R, Hagedorn CH (2014) Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures. J Gen Virol 95:423-433. doi: 10.1099/vir.0.055772-0 PMID: 24243732
50. Blight KJ, Kolykhalov AA, Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974. PMID: 11110665
51. Papic N, Maxwell CI, Delker DA, Liu S, Heale BS, Hagedorn CH (2012) RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection. Viruses 4:581-612. doi: 10.3390/v4040581 PMID: 22590687
52. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, Harris HJ, et al. (2008) Hepatitis C virus cellcell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47:17-24. PMID: 17941058
53. Auld DS, Thorne N, Maguire WF, Inglese J (2009) Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci USA 106:3585-3590. doi: 10.1073/pnas.0813345106 PMID: 19208811
54. Abe I, Umehara K, Morita R, Nemoto K, Degawa M, Noguchi H (2001) Green tea polyphenols as potent enhancers of glucocorticoid-induced mouse mammary tumor virus gene expression. Biochem Biophys Res Commun 281:122-125. PMID: 11178969
55. Lin LT, Chen TY, Lin SC, Chung CY, Lin TC, Wang GH, et al. (2013) Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol 13:187. doi: 10.1186/1471-2180-13-187 PMID: 23924316
56. Tsao R (2010) Chemistry and biochemistry of dietary polyphenols. Nutrients 2:1231-1246. doi: 10. 3390/nu2121231 PMID: 22254006
57. Le Bourvellec C, Renard CM (2012) Interactions between polyphenols and macromolecules: quantification methods and mechanisms. Critical reviews in food science and nutrition 52:213248.
58. Terrill TH, Waghorn GC, Woolley DJ, McNabb WC, Barry TN (1994) Assay and digestion of 14Clabelled condensed tannins in the gastrointestinal tract of sheep. Br J Nutr 72:467-477. PMID: 7947660
59. Bravo L, Abia R, Eastwood MA, Saura-Calixto F (1994) Degradation of polyphenols (catechin and tannic acid) in the rat intestinal tract. Effect on colonic fermentation and faecal output. Br J Nutr 71:933-946. PMID: 8031740
60. Zhu J, Filippich LJ, MT AL (1992) Tannic acid intoxication in sheep and mice. Res Vet Sci 53:280292.
61. Potter DK, Fuller HL (1968) Metabolic fate of dietary tannins in chickens. J Nutr 96:187-191. PMID: 5681147
62. Zhu J, Filippich LJ, Ng J (1995) Rumen involvement in sheep tannic acid metabolism. Vet Hum Toxicol 37:436-440. PMID: 8592830
63. Gin H, Rigalleau V, Caubet O, Masquelier J, Aubertin J (1999) Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro. Metabolism 48:1179-1183. PMID: 10484061
64. Meyer K, Kwon Y-C, Liu S, Hagedorn CH, Ray RB, Ray R (2015) Interferon-inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection. Scientific Reports 5:9012. doi: 10. 1038/srep09012 PMID: 25757571
65. Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, et al. (2010) Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J Exp Med 207:2019-2031. doi: 10.1084/jem.20090766 PMID: 20713596
66. Fofana I, Fafi-Kremer S, Carolla P, Fauvelle C, Zahid MN, Turek M, et al. (2012) Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. Gastroenterology 143:223-233 e229. doi: 10.1053/j.gastro.2012.04.006 PMID: 22503792
67. Crespo G, Marino Z, Navasa M, Forns X (2012) Viral hepatitis in liver transplantation. Gastroenterology 142:1373-1383 e1371. doi: 10.1053/j.gastro.2012.02.011 PMID: 22537446